Long-term Treatment Study of Certolizumab Pegol (CDP870) as Add-on Medication to Methotrexate in Japanese Rheumatoid Arthritis (RA) Patients
Clinical trial NCT00851318 · COMPLETED
Trial details
- NCT number
- NCT00851318
- Sponsor
- Astellas Pharma Inc
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2009-03-01
- Primary completion
- 2013-06-01
- Enrollment
- 285
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.